Age-related changes in the hepatic pharmacology and toxicology of paracetamol.

Effects of food on pharmacokinetics of immediate release oral formulations of simple analgesics: potential implications for drug use, safety and efficacy. Br J Clin Pharmacol (2015) 1.39

A Sieve-Raft Hypothesis for the regulation of endothelial fenestrations. Comput Struct Biotechnol J (2013) 0.78

Age-related loss of responsiveness to 2,5-dimethoxy-4-iodoamphetamine in liver sinusoidal endothelial cells. J Gerontol A Biol Sci Med Sci (2013) 0.77

Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays. Biomed Res Int (2017) 0.76

[Drug interactions in pain therapy]. Schmerz (2015) 0.75

[Non-opioid pain medication in the elderly]. Schmerz (2015) 0.75

Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38

A global clinical measure of fitness and frailty in elderly people. CMAJ (2005) 8.99

Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26

The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 8.23

Drug-induced hepatotoxicity. N Engl J Med (2003) 7.11

Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23

Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40

Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci U S A (2006) 3.97

Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89

Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA (1994) 3.80

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49

Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing (1992) 3.34

Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res (2005) 3.30

Aging biology and geriatric clinical pharmacology. Pharmacol Rev (2004) 3.23

Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A (2004) 3.07

Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf (2006) 3.06

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther (2004) 2.81

Acetaminophen poisoning and toxicity. Pediatrics (1975) 2.71

An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res (1970) 2.54

Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med (2007) 2.41

T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology (2006) 2.30

Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology (2004) 2.26

Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol (2001) 2.18

Acetaminophen hepatotoxicity. Clin Liver Dis (2007) 2.11

Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res (2010) 2.06

Adverse drug reactions in elderly patients. Br J Clin Pharmacol (2004) 2.02

The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther (2007) 2.00

Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology (2005) 2.00

Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res (1990) 1.97

Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology (2003) 1.92

Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet (2002) 1.88

Mitochondrial biogenesis and healthy aging. Exp Gerontol (2008) 1.85

The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology (1989) 1.80

Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs (1983) 1.70

Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70

Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology (2002) 1.68

Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology (1999) 1.68

Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol (2002) 1.68

Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology (2002) 1.67

Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol (1997) 1.66

Mechanisms of drug-induced liver injury. AAPS J (2006) 1.65

Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors. Ann Pharmacother (2002) 1.65

Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol (2009) 1.58

Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev (2009) 1.56

The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet (1998) 1.55

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology (1995) 1.54

A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J (2002) 1.51

Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem (2009) 1.50

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol (2004) 1.50

When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol (2003) 1.50

Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther (1997) 1.46

Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology (1995) 1.41

Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology (2001) 1.40

Age-related pseudocapillarization of the human liver. J Pathol (2003) 1.39

Drug-induced hepatotoxicity: 2005. J Clin Gastroenterol (2005) 1.38

Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology (1995) 1.36

Glutathione contents of tissues in the aging mouse. Biochem J (1980) 1.36

Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol (2006) 1.35

Sarcopenia, weight loss, and nutritional frailty in the elderly. Annu Rev Nutr (2002) 1.32

Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol (1992) 1.30

Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev (1997) 1.30

Paracetamol (acetaminophen) poisoning. Pharmacol Ther (1993) 1.28

Therapeutic misadventure with paracetamol: fact or fiction? Am J Ther (2000) 1.27

Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation (2003) 1.25

Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther (1991) 1.24

Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun (2003) 1.24

Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol (2007) 1.22

Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging (2005) 1.22

Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochem Pharmacol (2009) 1.21

Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur J Pharm Sci (2006) 1.20

Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation (1994) 1.20

Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol (2006) 1.19

Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. J Pharmacol Exp Ther (1982) 1.19

Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging (2001) 1.18

Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography. Clin Pharmacol Ther (2006) 1.18

Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet (1998) 1.17

The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet (2005) 1.14

Old age and the hepatic sinusoid. Anat Rec (Hoboken) (2008) 1.14

Age-related changes in the glutathione redox system. Cell Biochem Funct (2002) 1.14

Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one? J Pharmacol Exp Ther (2009) 1.14

Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains. Biochem Pharmacol (1997) 1.13

Free drug metabolic clearance in elderly people. Clin Pharmacokinet (2008) 1.12

Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice. Exp Toxicol Pathol (2007) 1.12

Low blood glutathione levels in healthy aging adults. J Lab Clin Med (1992) 1.10

Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis (2005) 1.09

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther (2010) 1.08

Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol (2003) 1.07

Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. J Pharmacol Exp Ther (1999) 1.04

Age-related changes in the hepatic microcirculation in mice. Exp Gerontol (2007) 1.02

Low alanine aminotransferase activity in older people is associated with greater long-term mortality. J Am Geriatr Soc (2006) 1.01

Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity. J Toxicol Environ Health A (2010) 1.01

Protective effects of resveratrol against acetaminophen-induced toxicity in mice. Hepatol Res (2006) 1.00

Basal activity of Kupffer cells increases with old age. J Gerontol A Biol Sci Med Sci (2007) 1.00

Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet (1997) 1.00

Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol Appl Pharmacol (1986) 0.98

Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol (2008) 0.97

Age and paracetamol self-poisoning. Gut (2005) 0.97

Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a 4-year experience. Intern Med J (2005) 0.95

Hospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004. BMC Public Health (2007) 0.95

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol (2012) 3.57

The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing (2009) 3.03

Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci (2009) 1.64

Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol (2009) 1.58

Prescribing in older people. Aust Fam Physician (2004) 1.49

Dietary approaches that delay age-related diseases. Clin Interv Aging (2006) 1.37

Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol (2011) 1.26

Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med (2012) 1.25

Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study. J Am Geriatr Soc (2009) 1.22

Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc (2011) 1.20

Medication exposure may confound the association between dietary intake and frailty. J Gerontol A Biol Sci Med Sci (2013) 1.08

Modifications to the drug burden index calculation may limit interpretation of its association with clinical outcomes in older adults. Neurocrit Care (2014) 1.07

Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging (2010) 1.07

Understanding drug effects in older people: the role of pharmacology. JAMA Intern Med (2013) 1.07

Review of epidemiology and management of atrial fibrillation in developing countries. Int J Cardiol (2013) 1.04

Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc (2015) 1.01

Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol (2011) 1.01

Hyperlipidemia and surfactants: the liver sieve is a link. Atherosclerosis (2006) 1.00

The liver sieve and atherosclerosis. Pathology (2012) 1.00

Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med (2011) 0.99

Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc (2014) 0.95

Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells. Int J Infect Dis (2010) 0.94

Drug burden index and beers criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol (2012) 0.94

Discontinuation of risperidone in Alzheimer's disease. N Engl J Med (2013) 0.92

Central nervous system medication use and incident mobility limitation in community elders: the Health, Aging, and Body Composition study. Pharmacoepidemiol Drug Saf (2009) 0.92

Discontinuation of statins in routine care settings. Ann Intern Med (2013) 0.92

Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf (2014) 0.91

Reactions of Pseudomonas aeruginosa pyocyanin with reduced glutathione. Acta Biochim Pol (2008) 0.90

Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging (2009) 0.90

The effect of Pseudomonas aeruginosa virulence factor, pyocyanin, on the liver sinusoidal endothelial cell. J Gastroenterol Hepatol (2007) 0.89

Prescription and administration of opioids to hospital in-patients, and barriers to effective use. Pain Med (2009) 0.89

Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: a population-level study. Drugs Aging (2013) 0.88

Liver sinusoidal endothelial cells and acute non-oxidative hepatic injury induced by Pseudomonas aeruginosa pyocyanin. Int J Exp Pathol (2008) 0.87

A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother (2010) 0.87

Assessing the harms of polypharmacy requires careful interpretation and consistent definitions. Br J Clin Pharmacol (2014) 0.87

Clinical implications of changes in hepatic drug metabolism in older people. Ther Clin Risk Manag (2005) 0.86

Caloric restriction reduces age-related pseudocapillarization of the hepatic sinusoid. Exp Gerontol (2007) 0.85

Poloxamer 407 increases the recovery of paracetamol in the isolated perfused rat liver. J Pharm Sci (2010) 0.85

Pseudomonas aeruginosa and the hyperlipidaemia of sepsis. Pathology (2009) 0.85

Drug Burden Index and hospitalization among community-dwelling older people. Drugs Aging (2012) 0.85

Age-related pseudocapillarization of the liver sinusoidal endothelium impairs the hepatic clearance of acetaminophen in rats. J Gerontol A Biol Sci Med Sci (2011) 0.84

High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health (2013) 0.84

Psychotropic drug use and alcohol drinking in community-dwelling older Australian men: the CHAMP study. Drug Alcohol Rev (2012) 0.83

Prevalence of Analgesic Use and Pain in People with and without Dementia or Cognitive Impairment in Aged Care Facilities: A Systematic Review and Meta-Analysis. Curr Clin Pharmacol (2015) 0.83

Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study. Drugs Aging (2010) 0.83

The effect of old age on liver oxygenation and the hepatic expression of VEGF and VEGFR2. Exp Gerontol (2007) 0.82

Associations between drug burden index and physical function in older people in residential aged care facilities. Age Ageing (2010) 0.82

Effects of drug burden index on cognitive function in older men. J Clin Psychopharmacol (2012) 0.81

The effect of aging on acetaminophen pharmacokinetics, toxicity and Nrf2 in Fischer 344 rats. J Gerontol A Biol Sci Med Sci (2013) 0.80

Estimation of lean body weight in older community-dwelling men. Br J Clin Pharmacol (2010) 0.80

Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights. Pharm Res (2014) 0.80

Associations between drug burden index and mortality in older people in residential aged care facilities. Drugs Aging (2012) 0.80

Caloric restriction versus drug therapy to delay the onset of aging diseases and extend life. Age (Dordr) (2005) 0.79

Emergency hospitalizations for adverse drug events. N Engl J Med (2012) 0.79

The influence of old age and poloxamer-407 on the hepatic disposition of diazepam in the isolated perfused rat liver. Pharmacology (2012) 0.78

Effects of old age on vascular complexity and dispersion of the hepatic sinusoidal network. Microcirculation (2008) 0.78

Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open (2013) 0.78

Potential contribution of medications to frailty. J Am Geriatr Soc (2012) 0.78

Improving medicine selection for older people - do we need an Australian classification for inappropriate medicines use? Aust Fam Physician (2012) 0.77

Rethinking psychotropics in nursing homes. Reply. Med J Aust (2013) 0.77

Characteristics of older and younger patients with suspected paracetamol toxicity. Australas J Ageing (2012) 0.77

Sedative load and functional outcomes in community-dwelling older Australian men: the CHAMP study. Fundam Clin Pharmacol (2012) 0.77

The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol (2014) 0.77

Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract (2016) 0.75

Measures of drug toxicity in older adults. Arch Intern Med (2008) 0.75

Frailty should be assessed using validated scales. Drugs Aging (2010) 0.75

Optimal cutoff of polypharmacy and outcomes - reply. J Clin Epidemiol (2013) 0.75

Age and opioid analgesia in an acute hospital population. Age Ageing (2008) 0.75

Mechanisms and implications of age-related changes in the liver. Curr Gerontol Geriatr Res (2012) 0.75

Reducing drugs in older adults is more. Arch Intern Med (2011) 0.75

Editorial: Medication Management for People with Dementia or Cognitive Impairment. Curr Clin Pharmacol (2015) 0.75

Use of PPIs are not associated with mortality in institutionalized older people. Arch Intern Med (2011) 0.75

Effects of old age on hepatocyte oxygenation. Ann N Y Acad Sci (2007) 0.75

Statin Therapy and Cognition in Older People: What is the Evidence? Curr Clin Pharmacol (2015) 0.75

Re-evaluating psychotropic drug use across care settings. J Am Geriatr Soc (2013) 0.75

Teaching geriatric medicine in Vietnam: Introduction of an interactive learning module for medical students. Australas J Ageing (2010) 0.75

Which Aged Care inpatients are potentially suitable for community-based acute care? Australas J Ageing (2011) 0.75

Alcohol consumption and tobacco smoking among community-dwelling older Australian men: the Concord Health and Ageing in Men Project. Australas J Ageing (2013) 0.75